A new product containing a patented extract of the citrus fruit bergamot boasting ‘statin-like’ qualities - without the side effects - has been launched in the US claiming to tackle the key components of metabolic syndrome.

BergaMet MEGA, which has just launched in Europe and has been successful in Australia, is now available to US consumers online and is distributed directly to health care practitioners, its US distributor Nathealth Solutions told NutraIngredients-USA.

The multiple properties of the bergamot fruit allow it to work at many levels in cardiovascular prevention

‘Diabesity’ or metabolic syndrome, is characterized by a group of metabolic risk factors including central obesity, high triglycerides and LDL cholesterol, elevated blood pressure, insulin resistance or glucose intolerance, and being in a pro-inflammatory state (eg. high C-reactive protein levels in the blood).

Those with some or all of the above factors are at higher risk of developing type 2 diabetes or heart conditions.

While many plant-based ingredients are proven to have beneficial effects on one of these risk factors, a growing body of clinical evidence suggests that bergamot fruit - which is grown in the Calabria region of Southern Italy - has a positive impact on several of them, claimed cardiologist Ross Walker, MD, chief international medical advisor for Nathealth Solutions.

“The multiple properties of the bergamot fruit allow it to work at many levels in cardiovascular prevention. A recent study from Italy has also demonstrated a synergistic action with statins.”

Statin-like properties

A 30-day randomized controlled study
* published last April in the journal Fitoterapia led by researchers at the Department of Cardiology at the University in Rome on the effect of bergamot extract in diet-induced hyperlipemia in Wistar rats and in 237 patients suffering from hyperlipemia, showed that it reduced total and LDL cholesterol, triglycerides and blood glucose, while raising HDL.

The authors added: “On the basis of our data, bergamot extract oral supplements contribute to lowering plasma cholesterol and lipids in a rat model of diet-induced hyperlipemia and in patients, in a range of potency comparable with low dose statins.

“Thus they offer a safe alternative for patients suffering from statins toxicity. In addition, the possibility to reduce blood glucose by 15–25% suggests a phytotherapeutic approach to control the prediabetic states in patients with metabolic syndrome.”

Mechanism of action

But what is the mechanism of action?

Bergamot has a unique profile of flavonoid and flavonoid glycosides in its juice and albedo (the white coating under the rind) such as neoeriocitrin, neohesperidin, naringin, rutin, neodesmin, rhoifolin and poncirin, which have been shown to have positive cardiovascular effects
in multiple animal studies, added the authors.

“Since bergamot juice was shown to enhance the excretion of fecal sterols in rats, such a mechanism may contribute to its hypolipemic and hypoglycemic effect found in patients under bergamot extract treatment.

“Evidence also exists that dietary hesperetin reduces hepatic TG accumulation and this is associated with the reduced activity of TG synthetic enzymes, such as phosphatidate phosphohydrolase.

“In addition, the classical glycoside derivative of naringenin, which is naringin, has been shown to inhibit hepatic HMG-CoA reductase. Therefore it is likely that melitidine and brutieridine [derivatives of hesperetin and naringenin] in concert with naringin and other flavonone glycosides, might be responsible for the striking potency of bergamot extract in reducing cholesterol levels.”

Meanwhile, the antioxidant and anti-inflammatory effects of bergamot extracts also had beneficial effects on measures of endothelial function, they said.

“AMPK is also an important target of [diabetes drug] metformin. To ensure the energy production, AMPK not only facilitates glucose uptake, but triggers several catabolic and blocks anabolic pathways. First of all, AMPK prevents the accumulation of fat by modulating downstream-signalling components like acetyl-CoA carboxylase (ACC) and HMG-CoA reductase. AMPK phosphorylates and inhibits ACC1 activity, which blocks the rate-limiting step in fatty acid synthesis.

“On the other hand phosphorylation of ACC2 by AMPK augments fatty acid oxidation, which is a catabolic pathway for fat deposits. According to the studies of the ‘fatty mice model’, a high-fat diet reduces the basal activity levels of AMPK, suggesting that a certain level of AMPK basal activity may be necessary to prevent fat accumulation.”

One BergaMet tablet contains 650 mg of bergamot dehydrated juice. Recommended dosage is one tablet twice daily, 20-30 minutes before the two largest meals of the day.

A new product containing a patented extract of the citrus fruit bergamot boasting ‘statin-like’ qualities - without the side effects - has been launched in the US claiming to tackle the key components of metabolic syndrome.

Related products

Live Supplier Webinar

13-Mar-2015 -
Recent years have seen rampant omega-3 growth in all regions and sectors but scientific, environmental and economic headwinds have arrived and the sector is scrambling to adapt even as the global market pushed beyond €25bn.
What education actions have been...

Live Supplier Webinar

30-Mar-2015 - Consumer surveys show that the awareness for a healthy diet and lifestyle increases among consumers worldwide. Sugar content and carbohydrate quality are more and more in the focus.Also the scientific community agrees that blood sugar management matters to all of...

Technical / white paper

26-Mar-2015 - PLX® from Monteloeder is a natural plant extract that has been shown in clinical trials to combat the effects of oxidative stress. The benefits it offers are perfect for sportsmen and women, and older consumers looking to maintain an active...

Data sheet

10-Feb-2015 - Oximacro® is a cranberry powder and liquid extract with the highest content of Proanthocyanidins (PACs, 36%) on the market.It is produced by Biosfered S.r.l. – an Academic Spin-Off of the University of Turin, Italy – using its proprietary technology, and its...

Data sheet

09-Feb-2015 - AstaPure® is natural Astaxanthin from Haematococcus pluvialis. Our partner Algatechnologies employs a closed tubular and environmentally-protected cultivation system for the production of its natural astaxanthin AstaPure®. This technology allows for a highly controlled cultivation system, eliminating the introduction of foreign...

Clinical study

18-Mar-2015 - Obesity and overweight are considered to be major risk factors for a number of metabolic diseases such as diabetes, hypertension and cardiovascular diseases, leading to reduced life expectancy. Therapeutic weight loss includes a combination of diet, exercise and behaviour modification,...

Clinical study

18-Mar-2015 - Nourish the skin from the inside out withPycnogenol®, French maritime pine bark extract.Decades of research on Pycnogenol® have shown it effectively improves visible signs of aging by improving skin hydration and elasticity, reduces the appearance of over-pigmentation and skin inflammation....

Technical / white paper

17-Mar-2015 - Inflammation affects heart health, arthritis and many other health issues – and growing evidence suggests that nutrition is part of the solution. Seize this opportunity with custom nutrient premixes.Any nutrient. Any application. Anywhere in the world.

Data sheet

16-Mar-2015 - KinOmegaTM TGN Omega-3 EPA/DHA Fatty Acids concentrates are produced through the Proprietary Enzymatic Process with the combination of unique Three-time Molecular Distillation purification technology. It is the improved generation and high quality Omega-3 EPA/DHA TG concentrates with high TG (Triglycerides...

Application note

23-Feb-2015 - Polaris has developed an innovative formulation containing ultra-concentrated marine oil Omega 3 stabilised with Qualitysilver® technology, helping to reach EFSA health claims with only 1 capsule a day. Take a closer look at this product for various health benefits: Brain...

Technical / white paper

01-Jan-2015 - Increasing studies support the importance of reduced glycemic response within our diet. Inulin has proven effects on reducing glycemic response while replacing sugars. In fact, EFSA has acknowledged that inulin has an effect on glycemic response.

Data sheet

30-Mar-2015 - In January, several NGOs, scientists and businesses officially came together to help fund important research projects in Antarctica. Organized under the Antarctic Wildlife Research Fund (AWR), these entities will actively raise money for research into krill, a small crustacean that has...

Technical / white paper

23-Mar-2015 - Read more about Sanomed’s new, design-optimized 60 ml Minidrink bottle that is paving the way for consumer-focused nutritional supplements. It’s the perfect tool to target consumers on an emotional level and to give products a distinctive personality.